News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Mahatme Sandesh
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Mahatme Sandesh (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $6.8, valued at
$272k
|
|
| 07/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| Mahatme Sandesh (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 4,500 shares
@ $0
Granted 7,000 options to buy
@ $11.88, valued at
$83.2k
|
|
| 06/10/2020 |
4
| Mahatme Sandesh (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 28,100 options to buy
@ $8.89, valued at
$249.8k
|
|
| 02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2019 |
4
| Mahatme Sandesh (EVP, CFO & CBO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Sold 125,000 shares
@ $125.5, valued at
$15.7M
Exercised 4,319 options to buy
@ $13.71, valued at
$59.2k
Exercised 4,138 options to buy
@ $13.71, valued at
$56.7k
Exercised 10,466 options to buy
@ $23.85, valued at
$249.6k
Exercised 69,479 options to buy
@ $29.03, valued at
$2M
Exercised 21,875 options to buy
@ $32.63, valued at
$713.8k
Exercised 14,723 options to buy
@ $34.92, valued at
$514.1k
|
|
| 08/22/2019 |
4
| Mahatme Sandesh (EVP, CFO & CBO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 57,465 shares
@ $101.5, valued at
$5.8M
Gifted 42,535 shares
@ $0
Exercised 100,000 rights
@ $23.85, valued at
$2.4M
|
|
| 08/15/2019 |
4
| Mahatme Sandesh (EVP, CFO & CBO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Exercised 2,863 options to buy
@ $34.92, valued at
$100k
Exercised 3,021 options to buy
@ $29.03, valued at
$87.7k
Exercised 2,625 options to buy
@ $13.9, valued at
$36.5k
Exercised 985 options to buy
@ $13.71, valued at
$13.5k
Exercised 260 options to buy
@ $13.71, valued at
$3.6k
|
|
| 06/21/2019 |
4
| Mahatme Sandesh (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 12,500 options to buy
@ $11.74, valued at
$146.8k
|
|
| 06/07/2019 |
4
| Mahatme Sandesh (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 12,400 options to buy
@ $6.33, valued at
$78.5k
|
|
| 03/29/2019 |
4
| Mahatme Sandesh (EVP, CFO & CBO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Granted 6,649 shares
@ $0
Paid exercise price by delivering 2,953 shares
@ $118.68, valued at
$350.5k
|
|
| 03/20/2019 |
4
| Mahatme Sandesh (EVP, CFO & CBO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,625 shares
@ $126.47, valued at
$332k
Exercised 11,768 options to buy
@ $23.85, valued at
$280.7k
Exercised 3,511 options to buy
@ $13.9, valued at
$48.8k
Exercised 164 options to buy
@ $13.71, valued at
$2.2k
Exercised 43 options to buy
@ $13.71, valued at
$589.5 |
|
| 03/04/2019 |
4
| Mahatme Sandesh (EVP, CFO & CBO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Disposed/sold 4,781 shares
@ $0
Granted 55,000 options to buy
@ $145.48, valued at
$8M
|
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2018 |
4
| Mahatme Sandesh (EVP, CFO & CBO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Sold 107,524 shares
@ $127.74, valued at
$13.7M
Gifted 12,012 shares
@ $0
Gifted 12,012 shares
@ $0
Exercised 9,596 options to buy
@ $23.85, valued at
$228.9k
Exercised 39,006 options to buy
@ $13.9, valued at
$542.2k
Exercised 29,080 options to buy
@ $13.71, valued at
$398.7k
Exercised 11,718 options to buy
@ $13.71, valued at
$160.7k
|
|
| 08/08/2018 |
4
| Mahatme Sandesh (EVP, CFO & CBO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 8,501 shares
@ $121.02, valued at
$1M
|
|
| 06/21/2018 |
4
| Mahatme Sandesh (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 12,500 options to buy
@ $28.14, valued at
$351.8k
|
|
| 06/08/2018 |
4
| Mahatme Sandesh (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 18,400 options to buy
@ $10.28, valued at
$189.2k
|
|
| 05/24/2018 |
4
| Mahatme Sandesh (EVP, CFO & CBO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 2,024 shares
@ $89.22, valued at
$180.6k
Exercised 6,649 restricted stock units
@ $0 |
|
| 03/16/2018 |
4
| Mahatme Sandesh (EVP, CFO & CBO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 734 shares
@ $81.22, valued at
$59.6k
Exercised 2,500 options to buy
@ $23.85, valued at
$59.6k
|
|
| 03/07/2018 |
4
| Mahatme Sandesh (EVP, CFO & CBO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Granted 97,500 options to buy
@ $71.45, valued at
$7M
|
|
| 12/05/2017 |
4
| Mahatme Sandesh (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.73, valued at
$141.9k
|
|
| 08/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/19/2016 |
4
| Mahatme Sandesh (Senior Vice President, CFO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Sold 30,000 shares
@ $50.0834, valued at
$1.5M
Exercised 30,000 options to buy
@ $13.9, valued at
$417k
|
|
| 09/21/2016 |
4
| Mahatme Sandesh (Senior Vice President, CFO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Granted 524 shares
@ $0
Granted 23,906 shares
@ $0 |
|
| 09/02/2016 |
4
| Mahatme Sandesh (Senior Vice President, CFO) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,013 shares
@ $26.07, valued at
$26.4k
|
|
| 06/22/2016 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
|
|
|